Loading...
Poor Prognosis With Coexistence Of EGFR T790M Mutation And Common EGFR-Activating Mutation In Non- Small Cell Lung Cancer
PURPOSE: Previous studies have shown that the presence of EGFR T790M mutation may reduce the treatment efficacy of tyrosine kinase inhibitors (TKIs) in EGFR-mutant lung cancer. However, little is known about the clinical features and outcomes of EGFR T790M mutation in pretreated patients with NSCLC....
Na minha lista:
| Udgivet i: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6859090/ https://ncbi.nlm.nih.gov/pubmed/32009817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S216721 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|